Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2018 | 08-2018 | 05-2018 | 02-2018 | 11-2017 | |
| Sales | 22 | 96 | 140 | 172 | 25 |
| Cost of Goods | 2 | 3 | 2 | 14 | 6 |
| Gross Profit | 20 | 93 | 138 | 158 | 19 |
| Operating Expenses | 712 | 1,320 | 3,559 | 1,535 | 588 |
| Operating Income | -692 | -1,227 | -3,421 | -1,377 | -569 |
| Other Income | -10 | 0 | -4 | -1 | -9 |
| Pre-tax Income | -701 | -1,227 | -3,425 | -1,378 | -579 |
| Net Income Continuous | -701 | -1,227 | -3,425 | -1,378 | -579 |
| Minority Interests | N/A | 10 | 0 | 0 | 0 |
| Net Income | $-701 | $-1,217 | $-3,425 | $-1,378 | $-579 |
| EPS Basic Total Ops | -0.30 | -0.30 | -1.50 | -0.60 | -0.30 |
| EPS Basic Continuous Ops | -0.30 | -0.30 | -1.50 | -0.60 | -0.30 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -1.50 | -0.60 | -0.30 |
| EPS Diluted Continuous Ops | -0.30 | -0.30 | -1.50 | -0.60 | -0.30 |
| EBITDA(a) | $-690 | $-1,226 | $-3,424 | $-1,378 | $-578 |